These tumorgrafts encompass the histological and clinical diversity of aggressive forms of human RCC, including 19 high-grade ccRCCs of which 65% had confirmed VHL mutations, 2 each of FH-deficient RCC and papillary RCC, 1 translocation RCC, and 4 unclassified RCC. The gene discussed is VHL; the disease is renal cell carcinoma.